Newsroom | 4931 results
Sorted by: Latest
-
Rhineland-Palatinate Biotech Company MODAG Receives Research Grant Funding from The Michael J. Fox Foundation
WENDELSHEIM, Germany--(BUSINESS WIRE)--MODAG GmbH announced it has received a $1 million research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF). This funding is part of MJFF’s strategic research agenda focused on supporting objective tools to biologically measure and track the progression of Parkinson’s disease (PD) to improve clinical trial design. The Foundation will support continued advancement of MODAG's innovative PET tracer programs, which enable earlier and mo...
-
Hyperfine Announces Regulatory Approval of the Swoop® System in India
GUILFORD, Conn.--(BUSINESS WIRE)--Swoop® portable MRI system receives CDSCO approval in India, expanding access to advanced brain imaging in a large, fast-growing healthcare market....
-
NorthStar Medical Radioisotopes to Present at the 44th Annual J.P. Morgan Healthcare Conference
BELOIT, Wis.--(BUSINESS WIRE)--NorthStar Medical Radioisotopes, LLC (NorthStar), a leading radiopharmaceutical company, today announced that Dr. Frank Scholz, President and Chief Executive Officer will present a company overview and update at the 44th Annual J.P. Morgan Healthcare Conference. The presentation will take place on Wednesday, January 14th at 2:00pm PT at the Westin St. Francis Hotel in San Francisco. About NorthStar Medical Radioisotopes, LLC (NorthStar) NorthStar Medical Radioisot...
-
Biotechnologieunternehmen MODAG aus Rheinland-Pfalz erhält Forschungsförderung von der Michael J. Fox Foundation
WENDELSHEIM, Deutschland--(BUSINESS WIRE)--Die MODAG GmbH gab heute bekannt, dass sie Fördermittel in Höhe von 1 Million US-Dollar von der Michael J. Fox Foundation for Parkinson’s Research (MJFF) erhalten hat. Diese Mittel sind Teil der strategischen Forschungsförderung der MJFF, die darauf abzielt, die Entwicklung objektiver Methoden zu unterstützen, die es ermöglichen bei Patienten mit Parkinson das Fortschreiten der Krankheit auf molekularer Ebene zu verfolgen. Dies soll auch das Design kli...
-
Healthcare Administrative Partners Provides North Broward Radiologists with Comprehensive Revenue Cycle Management Services
MEDIA, Pa.--(BUSINESS WIRE)--Healthcare Administrative Partners (HAP), a leading provider of outsourced billing, coding, and practice management solutions for radiology practices, today announces the addition of North Broward Radiologists in Fort Lauderdale, FL to its roster of revenue cycle management clients. North Broward Radiologists is a trusted, board-certified medical practice serving Broward County, Florida, with decades of experience providing exceptional diagnostic imaging and radiolo...
-
Hologic’s AI-Powered Mammography Technology Flagged a Third of Breast Cancer Cases Initially Interpreted as Negative in Study of 7,500 Screening Exams
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic’s AI-Powered Mammography Technology Flagged a Third of Breast Cancer Cases Initially Interpreted as Negative in Study of 7,500 Screening Exams...
-
Kathy Spencer-Pike Joins NorthStar Medical Radioisotopes, LLC as Chief Commercial Officer
BELOIT, Wis.--(BUSINESS WIRE)--NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging, today announced the appointment of Kathy Spencer-Pike as Chief Commercial Officer, effective December 1st 2025. In this role, Spencer-Pike will lead the company’s commercial strategy; overseeing sales, marketing, business development, customer engagement and market expansion ini...
-
Victor Miller Joins NorthStar Medical Radioisotopes, LLC as Chief Financial Officer
BELOIT, Wis.--(BUSINESS WIRE)--NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging, today announced the appointment of Victor Miller as Chief Financial Officer, effective December 1st 2025. With more than two decades of senior financial leadership in life sciences and biotechnology, Miller brings a proven track record of helping companies build scalable financi...
-
NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation
FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics announced that Natera has voluntarily withdrawn its appeal in ongoing RaDaR patent litigation....
-
Exact Sciences, the NSABP Foundation, and the German Breast Group Present Results for the Oncodetect® MRD Test in Early Triple-Negative Breast Cancer at SABCS
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the first clinical study results from its Oncodetect® molecular residual disease (MRD) test in breast cancer. Findings from the NSABP B-59 substudy, conducted in collaboration with the NSABP Foundation and the German Breast Group (GBG), demonstrated that the Oncodetect test strongly predicts distant recurrence following surgery in patients with early...